Back to mobile site

Analyst Sees Potential for Omeros' (OMER) OMS824 as FDA Gives Clearance

May 23, 2013 1:37 PM EDT Send to a Friend
Wedbush today reiterated an Outperform rating on Omeros Corp. (NASDAQ: OMER) with a price target of $18.00. Comments follow news ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login